{"id":69534,"date":"2024-08-23T13:04:50","date_gmt":"2024-08-23T13:04:50","guid":{"rendered":"https:\/\/www.pharmacie-vezere.com\/promotions\/?p=69534"},"modified":"2024-08-23T13:05:25","modified_gmt":"2024-08-23T13:05:25","slug":"orladeyo-obtient-lapprobation","status":"publish","type":"post","link":"https:\/\/www.pharmacie-vezere.com\/promotions\/orladeyo-obtient-lapprobation\/","title":{"rendered":"ORLADEYO obtient l’approbation au P\u00e9rou pour la pr\u00e9vention de l’AOH"},"content":{"rendered":"

La capsule orale quotidienne a \u00e9t\u00e9 principalement d\u00e9velopp\u00e9e pour pr\u00e9venir les attaques d’AOH.
\nPint Pharma a annonc\u00e9 l’approbation au P\u00e9rou d’Orladeyo (b\u00e9rotralstat) pour une utilisation en tant que th\u00e9rapie orale pour pr\u00e9venir les attaques d’angioed\u00e8me h\u00e9r\u00e9ditaire (AOH).<\/p>\n

Orladeyo est un produit de BioCryst Pharmaceuticals. Pint Pharma d\u00e9tient ses droits d’enregistrement, de commercialisation et de distribution en Am\u00e9rique latine (LATAM).<\/p>\n

Approuv\u00e9 par la Direction g\u00e9n\u00e9rale des m\u00e9dicaments, des fournitures et des drogues du P\u00e9rou, il est destin\u00e9 \u00e0 la prophylaxie des attaques d’AOH chez les adultes et les enfants \u00e2g\u00e9s de 12 ans et plus.
\nL’angioed\u00e8me h\u00e9r\u00e9ditaire est un trouble g\u00e9n\u00e9tique. Il se traduit par des \u00e9pisodes r\u00e9currents de gonflement douloureux des muqueuses, de la peau et des tissus sous-muqueux.<\/p>\n

Le directeur scientifique de Pint Pharma, le Dr Valnei Canutti, a d\u00e9clar\u00e9: “L’approbation d’Orladeyo par le DIGEMID est une excellente nouvelle pour la communaut\u00e9 de patients atteints d’angioed\u00e8me h\u00e9r\u00e9ditaire au P\u00e9rou.<\/p>\n

“Cette th\u00e9rapie orale innovante repr\u00e9sente une avanc\u00e9e pour ceux qui vivent avec cette maladie rare, offrant une option de prophylaxie efficace et pratique \u00e0 long terme, pr\u00e9venant les attaques d’angioed\u00e8me h\u00e9r\u00e9ditaire.”
\nLa capsule orale quotidienne a \u00e9t\u00e9 principalement d\u00e9velopp\u00e9e pour pr\u00e9venir les attaques d’AOH en inhibant l’activit\u00e9 de la callicr\u00e9ine plasmatique.<\/p>\n

Le PDG de Pint Pharma<\/a>, David Mu\u00f1oz, a d\u00e9clar\u00e9: “En plus d’apporter des avantages directs aux patients, la disponibilit\u00e9 d’Orladeyo au P\u00e9rou souligne notre engagement continu envers l’avancement de la recherche et de l’innovation dans le domaine des soins m\u00e9dicaux pour les maladies rares.”<\/p>\n

Le directeur g\u00e9n\u00e9ral du cluster nord de Pint Pharma LATAM, Mauricio Botero, a d\u00e9clar\u00e9: “L’approbation d’Orladeyo est une grande r\u00e9ussite pour les patients et la preuve de la collaboration r\u00e9ussie entre la communaut\u00e9 m\u00e9dicale, les r\u00e9gulateurs et les entreprises pharmaceutiques au P\u00e9rou pour am\u00e9liorer les options de traitement.”
\nEn 2023, BioCryst a obtenu l’autorisation de commercialisation de l’Institut de sant\u00e9 publique du Chili pour ORLADEYO.<\/p>\n","protected":false},"excerpt":{"rendered":"

La capsule orale quotidienne a \u00e9t\u00e9 principalement d\u00e9velopp\u00e9e pour pr\u00e9venir les attaques d’AOH. Pint Pharma a annonc\u00e9 l’approbation au P\u00e9rou d’Orladeyo (b\u00e9rotralstat) pour une utilisation en tant que th\u00e9rapie orale pour pr\u00e9venir les attaques d’angioed\u00e8me h\u00e9r\u00e9ditaire (AOH). Orladeyo est un produit de BioCryst Pharmaceuticals. Pint Pharma d\u00e9tient ses droits d’enregistrement, de commercialisation et de distribution […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[684],"tags":[],"class_list":["post-69534","post","type-post","status-publish","format-standard","hentry","category-nouvelles-pharmaceutiques"],"_links":{"self":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69534","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/comments?post=69534"}],"version-history":[{"count":1,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69534\/revisions"}],"predecessor-version":[{"id":69535,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69534\/revisions\/69535"}],"wp:attachment":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/media?parent=69534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/categories?post=69534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/tags?post=69534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}